Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N7GN
|
|||
| Former ID |
DIB007398
|
|||
| Drug Name |
Aerucin
|
|||
| Synonyms |
AR-105; Monoclonal antibody (inhaler, Pseudomonas lung infection); Anti-P aeruginosa alginate antibody (dry powder inhalant formulation), Aridis; Monoclonal antibody (inhaler, Pseudomonas lung infection), Aridis
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Pneumocystis pneumonia [ICD-11: CA40.20; ICD-10: B59] | Phase 2 | [1] | |
| Pseudomonas infection [ICD-11: 1B92; ICD-10: A24, A24.0] | Phase 1 | [2] | ||
| Company |
Harvard Medical School
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03027609) Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin) in P. Aeruginosa Pneumonia. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02486770) Study of Single Doses of IV Aerucin in Healthy Adults. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.